ArticlePediatric blood & cancer2023

Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.

Kelly E Faulk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.